Breaking News Instant updates and real-time market news.

MYGN

Myriad Genetics

$21.35

0.165 (0.78%)

14:59
10/09/16
10/09
14:59
10/09/16
14:59

Myriad Genetics says tumor test doubles patient identification

Myriad Genetics (MYGN) announced that its myChoice HRD test identified more than double the number of patients who may benefit from treatment with niraparib than were identified by germline BRCA testing alone. The myChoice HRD test was evaluated in the NOVA study of nirarapib, an investigational oral PARP inhibitor being developed by TESARO (TSRO). "Patients with ovarian cancer who tested positive with myChoice HRD experienced a clinically meaningful improvement in PFS. We estimate that myChoice HRD identifies more than double the number of patients who may benefit compared to germline BRCA testing alone," said Myriad.

  • 09

    Oct

MYGN Myriad Genetics
$21.35

0.165 (0.78%)

08/10/16
GABE
08/10/16
DOWNGRADE
GABE
Hold
Myriad Genetics downgraded to Hold from Buy at Gabelli
Gabelli analyst Sara Wojda downgraded Myriad Genetics to Hold following Q4 results and lowered her FY17 estimates to include the impact of the Assurex acquisition and declining hereditary cancer segment.
08/10/16
08/10/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. SunPower (SPWR) downgraded to Neutral from Overweight at JPMorgan, to Perform from Outperform at Oppenheimer, to Hold from Buy at Deutsche Bank, to Neutral from Buy at Janney Capital, to Neutral from Outperform at Credit Suisse, and to Market Perform from Outperform at Avondale. 2. Noble Corp. (NE) downgraded to Sell from Hold at Argus with analyst David Coleman saying the company is being hurt by declining offshore drilling activity, lower fleet utilization and falling day rates. 3. Wayfair (W) downgraded to Neutral from Buy at Goldman and to Neutral from Buy at BofA/Merrill. 4. Buffalo Wild Wings (BWLD) downgraded to Market Perform from Outperform at Raymond James with analyst Brian Vaccaro saying shares are fairly valued in the context of below average comp visibility in the near-term and largely discount the benefits of near-term potential activist proposals. 5. Myriad Genetics (MYGN) downgraded to Equal Weight from Overweight at Barclays, to Neutral from Overweight at Piper Jaffray, to Market Perform from Outperform at Wells Fargo, and to Hold from Buy at Gabelli. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/11/16
SPHN
08/11/16
NO CHANGE
Target $30
SPHN
Overweight
Myriad Genetics price target lowered to $30 from $47 at Stephens
Stephens analyst Drew Jones lowered his price target for Myriad Genetics to $30 from $47 after the company missed Q4 expectations slightly and issued "disappointing" 2017 guide. The analyst sees hereditary cancer as the "primary culprit," with sales turnover blamed for volume weakness. Further, Jones believes the lack of visibility into this weakness has created an overhang that will not be solved with "one decent quarter." He reiterates an Overweight rating on the shares.
08/29/16
BOFA
08/29/16
NO CHANGE
BOFA
Myriad Genetics loses BCBS of Nevada contract to LabCorp, says BofA/Merrill
Analysts at BofA Merrill Lynch noted that Myriad Genetics (MYGN) has lost an in-network contract with Blue Cross Blue Shield of Nevada to LabCorp (LH) and the firm expects Myriad shares to trade down following the news. The firm sees the potential for a continuation of this trend across other BCBS systems in other states.

TODAY'S FREE FLY STORIES

ACN

Accenture

$121.23

0.51 (0.42%)

15:17
02/20/17
02/20
15:17
02/20/17
15:17
Hot Stocks
Accenture announces intent to acquire SinnerSchrader »

Accenture announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGG

CGG SA

15:13
02/20/17
02/20
15:13
02/20/17
15:13
Hot Stocks
CGG SA says secures consent from debt holders »

CGG SA CGG announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PI

Impinj

$31.17

-4.19 (-11.85%)

15:05
02/20/17
02/20
15:05
02/20/17
15:05
Hot Stocks
Impinj announces partnership, platform integration with STANLEY Healthcare »

Impinj announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

HRS

Harris

$109.46

0.81 (0.75%)

15:03
02/20/17
02/20
15:03
02/20/17
15:03
Hot Stocks
Harris wins $189M contract with UAE military »

Harris has received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$100.52

-0.3 (-0.30%)

15:01
02/20/17
02/20
15:01
02/20/17
15:01
Hot Stocks
Alibaba announces strategic partnership with Bailian Group »

Alibaba and Chinese…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 19

    Mar

SWIR

Sierra Wireless

$27.80

1.575 (6.01%)

, VLKAY

Volkswagen

$30.87

-0.65 (-2.06%)

14:58
02/20/17
02/20
14:58
02/20/17
14:58
Hot Stocks
Sierra Wireless says connected car products selected by Volkswagen »

Sierra Wireless (SWIR)…

SWIR

Sierra Wireless

$27.80

1.575 (6.01%)

VLKAY

Volkswagen

$30.87

-0.65 (-2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGNX

Progenics

$10.62

0.08 (0.76%)

, CLMS

Calamos

$8.24

-0.03 (-0.36%)

14:55
02/20/17
02/20
14:55
02/20/17
14:55
Hot Stocks
Progenics to replace Calamos in S&P 600 as of 2/20 close »

Calamos Asset Management…

PGNX

Progenics

$10.62

0.08 (0.76%)

CLMS

Calamos

$8.24

-0.03 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 23

    Feb

  • 01

    Mar

SFLY

Shutterfly

$48.06

0.66 (1.39%)

, VASC

Vascular Solutions

14:55
02/20/17
02/20
14:55
02/20/17
14:55
Hot Stocks
Shutterfly to replace Vascular Solutions in S&P 600 as of 2/20 close »

S&P MidCap 400…

SFLY

Shutterfly

$48.06

0.66 (1.39%)

VASC

Vascular Solutions

TFX

Teleflex

$179.91

1.86 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

NKTR

Nektar

$13.10

0.12 (0.92%)

, BMY

Bristol-Myers

$54.59

0.31 (0.57%)

14:48
02/20/17
02/20
14:48
02/20/17
14:48
Hot Stocks
Nektar reports Phase 1 data on NKTR-214 in kidney cancer »

Nektar Therapeutics…

NKTR

Nektar

$13.10

0.12 (0.92%)

BMY

Bristol-Myers

$54.59

0.31 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 02

    Mar

  • 17

    Mar

  • 01

    Apr

XNCR

Xencor

$24.28

0.5 (2.10%)

14:38
02/20/17
02/20
14:38
02/20/17
14:38
Hot Stocks
Xencor announces data presentation on XmAb5871 »

Xencor announced it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

RHHBY

Roche

$30.53

0.02 (0.07%)

14:35
02/20/17
02/20
14:35
02/20/17
14:35
Hot Stocks
Genentech reports Phase 2 data on Tecentriq combo in kidney cancer »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 27

    Feb

  • 09

    Mar

  • 26

    Jun

RVSB

Riverview Bancorp

$7.50

-0.11 (-1.45%)

14:30
02/20/17
02/20
14:30
02/20/17
14:30
Hot Stocks
Breaking Hot Stocks news story on Riverview Bancorp »

Riverview Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCN

Ocwen

$5.24

0.09 (1.75%)

14:27
02/20/17
02/20
14:27
02/20/17
14:27
Hot Stocks
Ocwen reaches settlement, termination of California consent order »

Ocwen Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

SYF

Synchrony

$36.68

-0.17 (-0.46%)

14:07
02/20/17
02/20
14:07
02/20/17
14:07
Periodicals
Synchrony likely to see more gains, Barron's says »

Synchrony "still has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANTM

Anthem

$160.25

-3.52 (-2.15%)

, CI

Cigna

$143.56

-1.77 (-1.22%)

14:05
02/20/17
02/20
14:05
02/20/17
14:05
Periodicals
Merger collapse could get Anthem back on track, Barron's says »

The likely collapse of…

ANTM

Anthem

$160.25

-3.52 (-2.15%)

CI

Cigna

$143.56

-1.77 (-1.22%)

ESRX

Express Scripts

$69.97

0.74 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

QSR

Restaurant Brands

$53.90

0.05 (0.09%)

, PLKI

Popeyes

$66.12

-0.26 (-0.39%)

13:50
02/20/17
02/20
13:50
02/20/17
13:50
Periodicals
Restaurant Brands in advanced talks to buy Popeyes, Bloomberg says »

A deal could be announced…

QSR

Restaurant Brands

$53.90

0.05 (0.09%)

PLKI

Popeyes

$66.12

-0.26 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Mar

AAPL

Apple

$135.72

0.375 (0.28%)

, AMAT

Applied Materials

$35.67

0.49 (1.39%)

13:48
02/20/17
02/20
13:48
02/20/17
13:48
Periodicals
Smartphone design trends could benefit Applied Materials, others, Barron's says »

As Apple (AAPL) and other…

AAPL

Apple

$135.72

0.375 (0.28%)

AMAT

Applied Materials

$35.67

0.49 (1.39%)

OLED

Universal Display

$72.15

0.85 (1.19%)

GLW

Corning

$27.65

-0.06 (-0.22%)

SSNLF

Samsung

LPL

LG Display

$12.39

0.07 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 13

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

  • 28

    Mar

  • 01

    Apr

TOSBF

Toshiba, also use TOSYY

$1.61

-0.182 (-10.17%)

, TOSYY

Toshiba, also use TOSBF

$9.55

-1.085 (-10.21%)

13:32
02/20/17
02/20
13:32
02/20/17
13:32
Periodicals
Toshiba could have 50% upside, Barron's says »

Toshiba shares are…

TOSBF

Toshiba, also use TOSYY

$1.61

-0.182 (-10.17%)

TOSYY

Toshiba, also use TOSBF

$9.55

-1.085 (-10.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIN

DineEquity

$60.14

-6.41 (-9.63%)

13:27
02/20/17
02/20
13:27
02/20/17
13:27
Periodicals
DineEquity remains challenged, Barron's says »

"Problems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

HD

Home Depot

$143.00

1.46 (1.03%)

13:09
02/20/17
02/20
13:09
02/20/17
13:09
Periodicals
Home Depot looks healthy into earnings report, Barron's says »

Home Depot remains the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 15

    Mar

ADNT

Adient

$64.01

-0.69 (-1.07%)

, JCI

Johnson Controls

$41.91

0.23 (0.55%)

12:58
02/20/17
02/20
12:58
02/20/17
12:58
Periodicals
Adient could offer 35% upside, Barron's says »

Shares of Adient (ADNT)…

ADNT

Adient

$64.01

-0.69 (-1.07%)

JCI

Johnson Controls

$41.91

0.23 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HES

Hess Corp.

$51.75

0.45 (0.88%)

12:47
02/20/17
02/20
12:47
02/20/17
12:47
Periodicals
Steer clear of Hess Corp, Barron's says »

Hess Corp shares are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

GM

General Motors

$37.22

0.19 (0.51%)

12:33
02/20/17
02/20
12:33
02/20/17
12:33
Periodicals
General Motors stock could reach $50 in a year, Barron's says »

Shares of General Motors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

11:43
02/20/17
02/20
11:43
02/20/17
11:43
Conference/Events
DA Davidson E&C and industrials analysts hold analyst/industry conference call »

E&C, Materials &…

11:38
02/20/17
02/20
11:38
02/20/17
11:38
Conference/Events
DA Davidson technology/software analysts hold analyst/industry conference call »

Technology Analyst…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.